Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Doriano Fabbro

Showing results (21-30 of 121) with videos related to

Pageof 13
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|October 1, 2011
Targeting cancer with small-molecular-weight kinase inhibitorsDoriano Fabbro, Sandra W Cowan-Jacob, Henrik Möbitz, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 9, 2011
Characterization of kinase inhibitors using reverse phase protein arraysGeorg Martiny-Baron, Dorothea Haasen, Daniel D'Dorazio, et al.
Cancer Research|August 4, 2004
Differential activation of the phosphatidylinositol 3'-kinase/Akt survival pathway by ionizing radiation in tumor and primary endothelial cellsDaniel Zingg, Oliver Riesterer, Doriano Fabbro, et al.
Biochimica Et Biophysica Acta|October 18, 2003
Ceramide induces translocation of protein kinase C-alpha to the Golgi compartment of human embryonic kidney cells by interacting with the C2 domainArmaz Aschrafi, Rochus Franzen, Soheyla Shabahang, et al.
Journal of Medicinal Chemistry|June 13, 2003
Discovery of a potent and selective protein kinase CK2 inhibitor by high-throughput dockingEric Vangrevelinghe, Kaspar Zimmermann, Joseph Schoepfer, et al.
Anti-Cancer Drugs|August 12, 2008
In-vitro antiproliferative activities and kinase inhibitory potencies of meridianin derivativesEmilie Rossignol, Eric Debiton, Doriano Fabbro, et al.
Nature Reviews. Drug Discovery|August 6, 2021
Trends in kinase drug discovery: targets, indications and inhibitor designMisty M Attwood, Doriano Fabbro, Aleksandr V Sokolov, et al.
Anti-Cancer Drugs|August 21, 2007
In-vitro antiproliferative activities and kinase inhibitory potencies of glycosyl-isoindigo derivativesMathieu Sassatelli, Fadoua Bouchikhi, Bettina Aboab, et al.
Biochimica Et Biophysica Acta|September 13, 2016
Upregulation of the S1P<sub>3</sub> receptor in metastatic breast cancer cells increases migration and invasion by induction of PGE<sub>2</sub> and EP<sub>2</sub>/EP<sub>4</sub> activationIuliia Filipenko, Stephanie Schwalm, Luca Reali, et al.
Proteomics. Clinical Applications|December 8, 2010
Tracing pathway activities with kinase inhibitors and reverse phase protein arraysJan van Oostrum, Claudio Calonder, Daniel Rechsteiner, et al.
Pageof 13

Showing results (21-30 of 121) with videos related to

Sort By:
Pageof 13
Methods in Molecular Biology (Clifton, N.J.)|October 1, 2011
Targeting cancer with small-molecular-weight kinase inhibitorsDoriano Fabbro, Sandra W Cowan-Jacob, Henrik Möbitz, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 9, 2011
Characterization of kinase inhibitors using reverse phase protein arraysGeorg Martiny-Baron, Dorothea Haasen, Daniel D'Dorazio, et al.
Cancer Research|August 4, 2004
Differential activation of the phosphatidylinositol 3'-kinase/Akt survival pathway by ionizing radiation in tumor and primary endothelial cellsDaniel Zingg, Oliver Riesterer, Doriano Fabbro, et al.
Biochimica Et Biophysica Acta|October 18, 2003
Ceramide induces translocation of protein kinase C-alpha to the Golgi compartment of human embryonic kidney cells by interacting with the C2 domainArmaz Aschrafi, Rochus Franzen, Soheyla Shabahang, et al.
Journal of Medicinal Chemistry|June 13, 2003
Discovery of a potent and selective protein kinase CK2 inhibitor by high-throughput dockingEric Vangrevelinghe, Kaspar Zimmermann, Joseph Schoepfer, et al.
Anti-Cancer Drugs|August 12, 2008
In-vitro antiproliferative activities and kinase inhibitory potencies of meridianin derivativesEmilie Rossignol, Eric Debiton, Doriano Fabbro, et al.
Nature Reviews. Drug Discovery|August 6, 2021
Trends in kinase drug discovery: targets, indications and inhibitor designMisty M Attwood, Doriano Fabbro, Aleksandr V Sokolov, et al.
Anti-Cancer Drugs|August 21, 2007
In-vitro antiproliferative activities and kinase inhibitory potencies of glycosyl-isoindigo derivativesMathieu Sassatelli, Fadoua Bouchikhi, Bettina Aboab, et al.
Biochimica Et Biophysica Acta|September 13, 2016
Upregulation of the S1P<sub>3</sub> receptor in metastatic breast cancer cells increases migration and invasion by induction of PGE<sub>2</sub> and EP<sub>2</sub>/EP<sub>4</sub> activationIuliia Filipenko, Stephanie Schwalm, Luca Reali, et al.
Proteomics. Clinical Applications|December 8, 2010
Tracing pathway activities with kinase inhibitors and reverse phase protein arraysJan van Oostrum, Claudio Calonder, Daniel Rechsteiner, et al.
Pageof 13